US5811447A
(en)
|
1993-01-28 |
1998-09-22 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
US6515009B1
(en)
|
1991-09-27 |
2003-02-04 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
US5985307A
(en)
|
1993-04-14 |
1999-11-16 |
Emory University |
Device and method for non-occlusive localized drug delivery
|
US5891108A
(en)
*
|
1994-09-12 |
1999-04-06 |
Cordis Corporation |
Drug delivery stent
|
US6231600B1
(en)
|
1995-02-22 |
2001-05-15 |
Scimed Life Systems, Inc. |
Stents with hybrid coating for medical devices
|
US6558798B2
(en)
|
1995-02-22 |
2003-05-06 |
Scimed Life Systems, Inc. |
Hydrophilic coating and substrates coated therewith having enhanced durability and lubricity
|
US6451047B2
(en)
|
1995-03-10 |
2002-09-17 |
Impra, Inc. |
Encapsulated intraluminal stent-graft and methods of making same
|
US6579314B1
(en)
*
|
1995-03-10 |
2003-06-17 |
C.R. Bard, Inc. |
Covered stent with encapsulated ends
|
US6264684B1
(en)
|
1995-03-10 |
2001-07-24 |
Impra, Inc., A Subsidiary Of C.R. Bard, Inc. |
Helically supported graft
|
US6743198B1
(en)
*
|
1995-03-20 |
2004-06-01 |
Conticare Medical, Inc. |
Self-cleansing bladder drainage device
|
US6099562A
(en)
*
|
1996-06-13 |
2000-08-08 |
Schneider (Usa) Inc. |
Drug coating with topcoat
|
US6322548B1
(en)
|
1995-05-10 |
2001-11-27 |
Eclipse Surgical Technologies |
Delivery catheter system for heart chamber
|
US5779673A
(en)
*
|
1995-06-26 |
1998-07-14 |
Focal, Inc. |
Devices and methods for application of intraluminal photopolymerized gels
|
US6283951B1
(en)
*
|
1996-10-11 |
2001-09-04 |
Transvascular, Inc. |
Systems and methods for delivering drugs to selected locations within the body
|
US6302875B1
(en)
|
1996-10-11 |
2001-10-16 |
Transvascular, Inc. |
Catheters and related devices for forming passageways between blood vessels or other anatomical structures
|
US5603694A
(en)
*
|
1995-10-17 |
1997-02-18 |
Brown; Joe E. |
Infusion coil apparatus and method for delivering fluid-based agents intravascularly
|
US6346510B1
(en)
|
1995-10-23 |
2002-02-12 |
The Children's Medical Center Corporation |
Therapeutic antiangiogenic endostatin compositions
|
US6402736B1
(en)
*
|
1996-02-16 |
2002-06-11 |
Joe E. Brown |
Apparatus and method for filtering intravascular fluids and for delivering diagnostic and therapeutic agents
|
SG64340A1
(en)
*
|
1996-02-27 |
1999-04-27 |
Inst Of Systems Science Nation |
Curved surgical instruments and methods of mapping a curved path for stereotactic surgery
|
US6783543B2
(en)
*
|
2000-06-05 |
2004-08-31 |
Scimed Life Systems, Inc. |
Intravascular stent with increasing coating retaining capacity
|
AU737078C
(en)
|
1996-05-24 |
2002-05-02 |
Angiotech Pharmaceuticals, Inc. |
Compositions and methods for treating or preventing diseases of body passageways
|
US6190402B1
(en)
*
|
1996-06-21 |
2001-02-20 |
Musc Foundation For Research Development |
Insitu formable and self-forming intravascular flow modifier (IFM) and IFM assembly for deployment of same
|
US5797887A
(en)
*
|
1996-08-27 |
1998-08-25 |
Novovasc Llc |
Medical device with a surface adapted for exposure to a blood stream which is coated with a polymer containing a nitrosyl-containing organo-metallic compound which releases nitric oxide from the coating to mediate platelet aggregation
|
US5944701A
(en)
*
|
1996-10-03 |
1999-08-31 |
Dubrul; William R. |
Self coiling catheter
|
US7341598B2
(en)
*
|
1999-01-13 |
2008-03-11 |
Boston Scientific Scimed, Inc. |
Stent with protruding branch portion for bifurcated vessels
|
US6379334B1
(en)
*
|
1997-02-10 |
2002-04-30 |
Essex Technology, Inc. |
Rotate advance catheterization system
|
CA2280729A1
(en)
*
|
1997-02-14 |
1998-08-20 |
Joe E. Brown |
Coil apparatus and method for delivering diagnostic and therapeutic agents intravascularly
|
JP3274384B2
(ja)
*
|
1997-03-31 |
2002-04-15 |
株式会社パイオラックス |
留置カテーテル及びその挿入装置
|
US5865815A
(en)
*
|
1997-04-25 |
1999-02-02 |
Contimed, Inc. |
Prostatic obstruction relief catheter
|
IT1293973B1
(it)
*
|
1997-08-13 |
1999-03-15 |
Sorin Biomedica Cardio Spa |
Elemento per l'ancoraggio in situ di dispositivi di impianto.
|
US6012034A
(en)
*
|
1997-08-18 |
2000-01-04 |
Becton, Dickinson And Company |
System and method for selecting an intravenous device
|
US20020055717A1
(en)
*
|
1997-10-20 |
2002-05-09 |
Philippe Poncet |
Fluid-based agent delivery device with self-expanding delivery element
|
US6168570B1
(en)
|
1997-12-05 |
2001-01-02 |
Micrus Corporation |
Micro-strand cable with enhanced radiopacity
|
US6241691B1
(en)
|
1997-12-05 |
2001-06-05 |
Micrus Corporation |
Coated superelastic stent
|
US6159165A
(en)
*
|
1997-12-05 |
2000-12-12 |
Micrus Corporation |
Three dimensional spherical micro-coils manufactured from radiopaque nickel-titanium microstrand
|
US6358229B1
(en)
*
|
1998-02-17 |
2002-03-19 |
Conticare Medical, Inc. |
Urinary drain
|
US7208010B2
(en)
|
2000-10-16 |
2007-04-24 |
Conor Medsystems, Inc. |
Expandable medical device for delivery of beneficial agent
|
US7208011B2
(en)
|
2001-08-20 |
2007-04-24 |
Conor Medsystems, Inc. |
Implantable medical device with drug filled holes
|
US6241762B1
(en)
|
1998-03-30 |
2001-06-05 |
Conor Medsystems, Inc. |
Expandable medical device with ductile hinges
|
US6296622B1
(en)
|
1998-12-21 |
2001-10-02 |
Micrus Corporation |
Endoluminal device delivery system using axially recovering shape memory material
|
US6500149B2
(en)
|
1998-08-31 |
2002-12-31 |
Deepak Gandhi |
Apparatus for deployment of micro-coil using a catheter
|
US6478773B1
(en)
*
|
1998-12-21 |
2002-11-12 |
Micrus Corporation |
Apparatus for deployment of micro-coil using a catheter
|
US6358276B1
(en)
*
|
1998-09-30 |
2002-03-19 |
Impra, Inc. |
Fluid containing endoluminal stent
|
US6375648B1
(en)
*
|
1998-10-02 |
2002-04-23 |
Misonix Incorporated |
Infiltration cannula with teflon coated outer surface
|
US6048332A
(en)
*
|
1998-10-09 |
2000-04-11 |
Ave Connaught |
Dimpled porous infusion balloon
|
US6293967B1
(en)
|
1998-10-29 |
2001-09-25 |
Conor Medsystems, Inc. |
Expandable medical device with ductile hinges
|
US6214042B1
(en)
*
|
1998-11-10 |
2001-04-10 |
Precision Vascular Systems, Inc. |
Micro-machined stent for vessels, body ducts and the like
|
US6413273B1
(en)
|
1998-11-25 |
2002-07-02 |
Israel Aircraft Industries Ltd. |
Method and system for temporarily supporting a tubular organ
|
US6258118B1
(en)
|
1998-11-25 |
2001-07-10 |
Israel Aircraft Industries Ltd. |
Removable support device
|
US6348067B1
(en)
*
|
1998-11-25 |
2002-02-19 |
Israel Aircraft Industries Ltd. |
Method and system with shape memory heating apparatus for temporarily supporting a tubular organ
|
US6835185B2
(en)
|
1998-12-21 |
2004-12-28 |
Micrus Corporation |
Intravascular device deployment mechanism incorporating mechanical detachment
|
JP3524788B2
(ja)
|
1998-12-24 |
2004-05-10 |
株式会社パイオラックス |
制癌剤投与用体内留置カテーテル
|
US6398803B1
(en)
|
1999-02-02 |
2002-06-04 |
Impra, Inc., A Subsidiary Of C.R. Bard, Inc. |
Partial encapsulation of stents
|
US6419692B1
(en)
|
1999-02-03 |
2002-07-16 |
Scimed Life Systems, Inc. |
Surface protection method for stents and balloon catheters for drug delivery
|
US6398758B1
(en)
*
|
1999-02-16 |
2002-06-04 |
Stephen C. Jacobsen |
Medicament delivery system
|
US20010041870A1
(en)
*
|
1999-03-09 |
2001-11-15 |
Edward M. Gillis |
Implantable device for access to a treatment site
|
US6702811B2
(en)
|
1999-04-05 |
2004-03-09 |
Medtronic, Inc. |
Ablation catheter assembly with radially decreasing helix and method of use
|
US6514236B1
(en)
|
1999-04-23 |
2003-02-04 |
Alexander A. Stratienko |
Method for treating a cardiovascular condition
|
US6245045B1
(en)
|
1999-04-23 |
2001-06-12 |
Alexander Andrew Stratienko |
Combination sheath and catheter for cardiovascular use
|
US6595959B1
(en)
|
1999-04-23 |
2003-07-22 |
Alexander A. Stratienko |
Cardiovascular sheath/catheter
|
US6156373A
(en)
*
|
1999-05-03 |
2000-12-05 |
Scimed Life Systems, Inc. |
Medical device coating methods and devices
|
US6290673B1
(en)
*
|
1999-05-20 |
2001-09-18 |
Conor Medsystems, Inc. |
Expandable medical device delivery system and method
|
US6478778B1
(en)
*
|
1999-05-28 |
2002-11-12 |
Precision Vascular Systems, Inc. |
Apparatus for delivering fluids to blood vessels, body cavities, and the like
|
AU763980B2
(en)
*
|
1999-06-16 |
2003-08-07 |
Medi-Tech Co., Ltd. |
Catheter
|
US6368315B1
(en)
*
|
1999-06-23 |
2002-04-09 |
Durect Corporation |
Composite drug delivery catheter
|
US6258121B1
(en)
|
1999-07-02 |
2001-07-10 |
Scimed Life Systems, Inc. |
Stent coating
|
US6494862B1
(en)
*
|
1999-07-13 |
2002-12-17 |
Advanced Cardiovascular Systems, Inc. |
Substance delivery apparatus and a method of delivering a therapeutic substance to an anatomical passageway
|
US6283947B1
(en)
|
1999-07-13 |
2001-09-04 |
Advanced Cardiovascular Systems, Inc. |
Local drug delivery injection catheter
|
US6350253B1
(en)
*
|
1999-07-19 |
2002-02-26 |
I-Flow Corporation |
Catheter for uniform delivery of medication
|
US7004923B2
(en)
*
|
1999-07-19 |
2006-02-28 |
I-Flow Corporation |
Catheter for uniform delivery of medication
|
US7452353B2
(en)
*
|
1999-07-19 |
2008-11-18 |
I-Flow Corporation |
Catheter for uniform delivery of medication
|
US7510550B2
(en)
*
|
1999-07-19 |
2009-03-31 |
I-Flow Corporation |
Catheter for uniform delivery of medication
|
US7547302B2
(en)
*
|
1999-07-19 |
2009-06-16 |
I-Flow Corporation |
Anti-microbial catheter
|
BR0014141A
(pt)
*
|
1999-08-25 |
2002-07-16 |
Univ Georgetown |
Sistema de aplicação para terapia que compreende bulbos ocos, preferivelmente metálicos, e a sua utilização
|
AU7720100A
(en)
|
1999-09-27 |
2001-04-30 |
Essex Technology, Inc. |
Rotate-to-advance catheterization system
|
JP2003510135A
(ja)
|
1999-09-29 |
2003-03-18 |
スターリング メディヴェイションズ インコーポレイテッド |
再使用可能な医薬注入装置
|
US6596235B2
(en)
|
1999-09-30 |
2003-07-22 |
Therox, Inc. |
Method for blood oxygenation
|
US7544500B2
(en)
|
1999-11-13 |
2009-06-09 |
Talecris Biotherapeutics, Inc. |
Process for the production of a reversibly inactive acidified plasmin composition
|
CA2391488C
(en)
|
1999-11-22 |
2012-04-03 |
Boston Scientific Limited |
Loop structures for supporting diagnostic and therapeutic elements in contact with body tissue
|
US7897140B2
(en)
*
|
1999-12-23 |
2011-03-01 |
Health Research, Inc. |
Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents
|
US7670327B2
(en)
*
|
2000-01-20 |
2010-03-02 |
Regents Of The University Of Minnesota |
Catheter systems for delivery of agents and related method thereof
|
US6663613B1
(en)
*
|
2000-01-25 |
2003-12-16 |
Bacchus Vascular, Inc. |
System and methods for clot dissolution
|
US6929633B2
(en)
|
2000-01-25 |
2005-08-16 |
Bacchus Vascular, Inc. |
Apparatus and methods for clot dissolution
|
US7740637B2
(en)
|
2000-02-09 |
2010-06-22 |
Micrus Endovascular Corporation |
Apparatus and method for deployment of a therapeutic device using a catheter
|
US6613082B2
(en)
|
2000-03-13 |
2003-09-02 |
Jun Yang |
Stent having cover with drug delivery capability
|
US6379382B1
(en)
|
2000-03-13 |
2002-04-30 |
Jun Yang |
Stent having cover with drug delivery capability
|
US7805188B2
(en)
*
|
2000-03-24 |
2010-09-28 |
Micor, Inc. |
Anesthesia conduction catheter for delivery of electrical stimulus
|
AU2001250969A1
(en)
|
2000-03-24 |
2001-10-03 |
Stephen Brushey |
Anesthesia conduction catheter
|
AU2001253479A1
(en)
*
|
2000-04-13 |
2001-10-30 |
Sts Biopolymers, Inc. |
Targeted therapeutic agent release devices and methods of making and using the same
|
US8236048B2
(en)
|
2000-05-12 |
2012-08-07 |
Cordis Corporation |
Drug/drug delivery systems for the prevention and treatment of vascular disease
|
US20040243097A1
(en)
*
|
2000-05-12 |
2004-12-02 |
Robert Falotico |
Antiproliferative drug and delivery device
|
US20050002986A1
(en)
*
|
2000-05-12 |
2005-01-06 |
Robert Falotico |
Drug/drug delivery systems for the prevention and treatment of vascular disease
|
US6776796B2
(en)
|
2000-05-12 |
2004-08-17 |
Cordis Corportation |
Antiinflammatory drug and delivery device
|
EP2111829B1
(de)
*
|
2000-06-05 |
2011-01-19 |
Boston Scientific Limited |
Intravaskulärer Stent mit verbessertem Haltevermögen einer Beschichtung
|
US6685672B1
(en)
*
|
2000-07-13 |
2004-02-03 |
Edwards Lifesciences Corporation |
Multi-balloon drug delivery catheter for angiogenesis
|
EP1322235B2
(de)
|
2000-09-29 |
2010-08-11 |
Cordis Corporation |
Beschichtete medizinische geräte
|
US20020111590A1
(en)
*
|
2000-09-29 |
2002-08-15 |
Davila Luis A. |
Medical devices, drug coatings and methods for maintaining the drug coatings thereon
|
US20020051730A1
(en)
*
|
2000-09-29 |
2002-05-02 |
Stanko Bodnar |
Coated medical devices and sterilization thereof
|
US7261735B2
(en)
*
|
2001-05-07 |
2007-08-28 |
Cordis Corporation |
Local drug delivery devices and methods for maintaining the drug coatings thereon
|
US6764507B2
(en)
|
2000-10-16 |
2004-07-20 |
Conor Medsystems, Inc. |
Expandable medical device with improved spatial distribution
|
WO2002032347A2
(en)
|
2000-10-16 |
2002-04-25 |
Conor Medsystems, Inc. |
Expandable medical device for delivery of beneficial agent
|
US6692458B2
(en)
|
2000-12-19 |
2004-02-17 |
Edwards Lifesciences Corporation |
Intra-pericardial drug delivery device with multiple balloons and method for angiogenesis
|
US20040073294A1
(en)
*
|
2002-09-20 |
2004-04-15 |
Conor Medsystems, Inc. |
Method and apparatus for loading a beneficial agent into an expandable medical device
|
US6964680B2
(en)
*
|
2001-02-05 |
2005-11-15 |
Conor Medsystems, Inc. |
Expandable medical device with tapered hinge
|
US7771468B2
(en)
*
|
2001-03-16 |
2010-08-10 |
Angiotech Biocoatings Corp. |
Medicated stent having multi-layer polymer coating
|
US6719804B2
(en)
*
|
2001-04-02 |
2004-04-13 |
Scimed Life Systems, Inc. |
Medical stent and related methods
|
DE10131152B4
(de)
*
|
2001-04-30 |
2004-05-27 |
Nutricia Healthcare S.A. |
Medizinisches Ballon-Button-System
|
DE60202677T2
(de)
*
|
2001-05-25 |
2005-12-29 |
Medtronic, Inc., Minneapolis |
Implantierbare medizinische vorrichtung mit kontrollierter freigabe von gasförmigen mitteln
|
US8252040B2
(en)
|
2001-07-20 |
2012-08-28 |
Microvention, Inc. |
Aneurysm treatment device and method of use
|
US6629969B2
(en)
*
|
2001-07-26 |
2003-10-07 |
Durect Corporation |
Catheter for modification of agent formulation
|
US7364565B2
(en)
*
|
2001-07-27 |
2008-04-29 |
Ramot At Tel Aviv University Ltd. |
Controlled enzymatic removal and retrieval of cells
|
US7842083B2
(en)
|
2001-08-20 |
2010-11-30 |
Innovational Holdings, Llc. |
Expandable medical device with improved spatial distribution
|
US7056338B2
(en)
|
2003-03-28 |
2006-06-06 |
Conor Medsystems, Inc. |
Therapeutic agent delivery device with controlled therapeutic agent release rates
|
US7195640B2
(en)
*
|
2001-09-25 |
2007-03-27 |
Cordis Corporation |
Coated medical devices for the treatment of vulnerable plaque
|
US7108701B2
(en)
*
|
2001-09-28 |
2006-09-19 |
Ethicon, Inc. |
Drug releasing anastomosis devices and methods for treating anastomotic sites
|
US20030065377A1
(en)
*
|
2001-09-28 |
2003-04-03 |
Davila Luis A. |
Coated medical devices
|
US20030065345A1
(en)
*
|
2001-09-28 |
2003-04-03 |
Kevin Weadock |
Anastomosis devices and methods for treating anastomotic sites
|
US6620202B2
(en)
|
2001-10-16 |
2003-09-16 |
Scimed Life Systems, Inc. |
Medical stent with variable coil and related methods
|
WO2003032916A2
(en)
*
|
2001-10-16 |
2003-04-24 |
Structural Bioinformatics Inc. |
Organosulfur inhibitors of tyrosine phosphatases
|
US6936040B2
(en)
*
|
2001-10-29 |
2005-08-30 |
Medtronic, Inc. |
Method and apparatus for endovenous pacing lead
|
US7438710B2
(en)
*
|
2001-11-07 |
2008-10-21 |
Anderson Kent D |
Distal protection device with local drug infusion by physician to maintain patency
|
US7041139B2
(en)
|
2001-12-11 |
2006-05-09 |
Boston Scientific Scimed, Inc. |
Ureteral stents and related methods
|
CN100393323C
(zh)
*
|
2002-02-13 |
2008-06-11 |
贝思·伊斯雷尔·迪科尼斯医药中心 |
治疗血管疾病的方法
|
US8506647B2
(en)
*
|
2002-02-14 |
2013-08-13 |
Boston Scientific Scimed, Inc. |
System for maintaining body canal patency
|
US8328877B2
(en)
|
2002-03-19 |
2012-12-11 |
Boston Scientific Scimed, Inc. |
Stent retention element and related methods
|
US20030191453A1
(en)
*
|
2002-04-03 |
2003-10-09 |
Velez Omar E. |
Catheter assembly
|
US9636174B2
(en)
|
2002-04-08 |
2017-05-02 |
Medtronic Ardian Luxembourg S.A.R.L. |
Methods for therapeutic renal neuromodulation
|
US8774913B2
(en)
|
2002-04-08 |
2014-07-08 |
Medtronic Ardian Luxembourg S.A.R.L. |
Methods and apparatus for intravasculary-induced neuromodulation
|
US7653438B2
(en)
|
2002-04-08 |
2010-01-26 |
Ardian, Inc. |
Methods and apparatus for renal neuromodulation
|
US7853333B2
(en)
|
2002-04-08 |
2010-12-14 |
Ardian, Inc. |
Methods and apparatus for multi-vessel renal neuromodulation
|
US20140018880A1
(en)
|
2002-04-08 |
2014-01-16 |
Medtronic Ardian Luxembourg S.A.R.L. |
Methods for monopolar renal neuromodulation
|
US8150519B2
(en)
|
2002-04-08 |
2012-04-03 |
Ardian, Inc. |
Methods and apparatus for bilateral renal neuromodulation
|
US7617005B2
(en)
|
2002-04-08 |
2009-11-10 |
Ardian, Inc. |
Methods and apparatus for thermally-induced renal neuromodulation
|
US20080213331A1
(en)
|
2002-04-08 |
2008-09-04 |
Ardian, Inc. |
Methods and devices for renal nerve blocking
|
US20070129761A1
(en)
|
2002-04-08 |
2007-06-07 |
Ardian, Inc. |
Methods for treating heart arrhythmia
|
US20070135875A1
(en)
|
2002-04-08 |
2007-06-14 |
Ardian, Inc. |
Methods and apparatus for thermally-induced renal neuromodulation
|
AU2003226366A1
(en)
|
2002-04-15 |
2003-11-03 |
Beth Israel Deaconess Medical Center |
Use of heme oxygenase-1 and products of heme degradation
|
US7122048B2
(en)
*
|
2002-05-03 |
2006-10-17 |
Scimed Life Systems, Inc. |
Hypotube endoluminal device
|
US8829198B2
(en)
*
|
2007-10-31 |
2014-09-09 |
Proteotech Inc |
Compounds, compositions and methods for the treatment of beta-amyloid diseases and synucleinopathies
|
PL375161A1
(en)
*
|
2002-06-21 |
2005-11-28 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
|
AU2003248747A1
(en)
|
2002-06-27 |
2004-01-19 |
Health Research, Inc. |
Fluorinated chlorin and bacteriochlorin photosensitizers for photodynamic therapy
|
EP2036908A3
(de)
*
|
2002-07-02 |
2009-05-13 |
Health Research, INC. |
Effiziente Synthese von Pyropheophorbid-A-Derivaten
|
AU2003256540B2
(en)
|
2002-07-12 |
2008-12-11 |
Cook Medical Technologies Llc |
Coated medical device
|
JP3887588B2
(ja)
*
|
2002-08-30 |
2007-02-28 |
株式会社リガク |
X線回折による応力測定法
|
US20040127976A1
(en)
*
|
2002-09-20 |
2004-07-01 |
Conor Medsystems, Inc. |
Method and apparatus for loading a beneficial agent into an expandable medical device
|
US20040059228A1
(en)
*
|
2002-09-23 |
2004-03-25 |
Scimed Life Systems, Inc. |
Systems and methods for flushing catheters
|
US7918819B2
(en)
*
|
2002-11-15 |
2011-04-05 |
Health & Human Services - NIH |
Variable curve catheter
|
JP5596896B2
(ja)
|
2003-03-28 |
2014-09-24 |
イノヴェイショナル・ホールディングズ・エルエルシー |
有益な薬剤の濃度勾配を有する、移植可能な医療装置の形成方法
|
WO2004099158A1
(en)
*
|
2003-04-30 |
2004-11-18 |
Ricerca Biosciences, Llc. |
Monocyclic diazodioxide based bcl-2 protein antagonists
|
WO2004099162A1
(en)
*
|
2003-04-30 |
2004-11-18 |
Ricerca Biosciences, Llc. |
Polycyclic diazodioxide-based bcl-2 protein antagonist
|
JP4824549B2
(ja)
|
2003-05-02 |
2011-11-30 |
サーモディクス,インコーポレイティド |
制御放出型の生体活性物質デリバリー・デバイス
|
WO2004110350A2
(en)
*
|
2003-05-14 |
2004-12-23 |
Torreypines Therapeutics, Inc. |
Compouds and uses thereof in modulating amyloid beta
|
US20090227647A1
(en)
*
|
2008-03-05 |
2009-09-10 |
Thomas Lake |
Compounds, Compositions and Methods for the Treatment of Islet Amyloid Polypeptide (IAPP) Accumulation in Diabetes
|
US8916598B2
(en)
|
2003-05-30 |
2014-12-23 |
Proteotech Inc |
Compounds, compositions, and methods for the treatment of β-amyloid diseases and synucleinopathies
|
US20040249364A1
(en)
*
|
2003-06-03 |
2004-12-09 |
Ilya Kaploun |
Device and method for dispensing medication to tissue lining a body cavity
|
US7169179B2
(en)
*
|
2003-06-05 |
2007-01-30 |
Conor Medsystems, Inc. |
Drug delivery device and method for bi-directional drug delivery
|
US20040260271A1
(en)
*
|
2003-06-18 |
2004-12-23 |
Huyser Richard F. |
Extended fenestration catheter with internal coil and method of making the same
|
US7057100B2
(en)
*
|
2003-06-26 |
2006-06-06 |
The J.C. Robinson Seed Co. |
Inbred corn line W23129
|
US7785653B2
(en)
|
2003-09-22 |
2010-08-31 |
Innovational Holdings Llc |
Method and apparatus for loading a beneficial agent into an expandable medical device
|
US20050101938A1
(en)
*
|
2003-11-06 |
2005-05-12 |
Leiboff Arnold R. |
Guidewire for use in colonic irrigation
|
WO2005090370A1
(en)
|
2004-02-05 |
2005-09-29 |
The Regents Of The University Of California |
Pharmacologically active agents containing esterified phosphonates and methods for use thereof
|
JP2007538103A
(ja)
|
2004-05-20 |
2007-12-27 |
ザ スクリップス リサーチ インスティテュート |
トランスサイレチン安定化
|
JP5054524B2
(ja)
|
2004-06-08 |
2012-10-24 |
アドバンスド ステント テクノロジーズ, インコーポレイテッド |
分岐管用突出枝部を備えたステント
|
WO2006009876A2
(en)
*
|
2004-06-17 |
2006-01-26 |
Cengent Therapeutics, Inc. |
Trisubstituted nitrogen modulators of tyrosine phosphatases
|
EP1786421A2
(de)
*
|
2004-07-09 |
2007-05-23 |
Cengent Therapeutics, Inc. |
Sauerstoff/stickstoff-heterozyklus-hemmer von tyrosinphosphatasen
|
FR2873016B1
(fr)
*
|
2004-07-15 |
2006-09-29 |
Pierre Marcel Bourgogne |
Protheses vasculaires artificielles delivrant en permanence des produits actifs empechant toute stenose, thrombose, proliferation cellulaire, etc.. d'acces aise permanent pour toute intervention
|
EP1778652A2
(de)
*
|
2004-08-20 |
2007-05-02 |
EntreMed, Inc. |
Zusammensetzungen und verfahren mit proteinaseaktivierten rezeptorantagonisten
|
EP1841749A1
(de)
*
|
2004-09-02 |
2007-10-10 |
Metabasis Therapeutics, Inc. |
Thiazol- und thiadiazolderivate als inhibitoren von tyrosinphosphatasen
|
AU2005287137B2
(en)
|
2004-09-17 |
2012-03-22 |
Foldrx Pharmaceuticals, Inc. |
Compounds, compositions and methods of inhibiting a-synuclein toxicity
|
US20060067889A1
(en)
*
|
2004-09-27 |
2006-03-30 |
Light Sciences Corporation |
Singlet oxygen photosensitizers activated by target binding enhancing the selectivity of targeted PDT agents
|
US20080140187A1
(en)
*
|
2004-10-15 |
2008-06-12 |
Krause Arthur A |
Anti-clotting, anti-microbial, anti-inflammatory medical stent
|
WO2006063199A2
(en)
|
2004-12-09 |
2006-06-15 |
The Foundry, Inc. |
Aortic valve repair
|
US8983582B2
(en)
|
2004-12-20 |
2015-03-17 |
Advanced Cardiovascular Systems, Inc. |
Methods and apparatuses for positioning within an internal channel
|
EP1861133B1
(de)
|
2005-02-28 |
2012-11-21 |
Spirus Medical Inc. |
System zur Katheterisierung durch drehende Einführung
|
WO2006137953A1
(en)
|
2005-04-01 |
2006-12-28 |
The Regents Of The Univerisity Of California |
Phosphono-pent-2-en-1-yl nucleosides and analogs
|
WO2006130217A2
(en)
*
|
2005-04-01 |
2006-12-07 |
The Regents Of The University Of California |
Substituted phosphate esters of nucleoside phosphonates
|
US20060229573A1
(en)
*
|
2005-04-08 |
2006-10-12 |
Mckinley Medical L.L.L.P. |
Adjustable infusion catheter
|
US8235942B2
(en)
|
2005-05-04 |
2012-08-07 |
Olympus Endo Technology America Inc. |
Rotate-to-advance catheterization system
|
US8317678B2
(en)
|
2005-05-04 |
2012-11-27 |
Olympus Endo Technology America Inc. |
Rotate-to-advance catheterization system
|
US8343040B2
(en)
|
2005-05-04 |
2013-01-01 |
Olympus Endo Technology America Inc. |
Rotate-to-advance catheterization system
|
US8414477B2
(en)
|
2005-05-04 |
2013-04-09 |
Olympus Endo Technology America Inc. |
Rotate-to-advance catheterization system
|
US7780650B2
(en)
|
2005-05-04 |
2010-08-24 |
Spirus Medical, Inc. |
Rotate-to-advance catheterization system
|
US7396366B2
(en)
|
2005-05-11 |
2008-07-08 |
Boston Scientific Scimed, Inc. |
Ureteral stent with conforming retention structure
|
WO2007002109A2
(en)
*
|
2005-06-20 |
2007-01-04 |
The Regents Of The University Of California |
Multidentate pyrone-derived chelators for medicinal imaging and chelation
|
US9162033B2
(en)
*
|
2005-06-27 |
2015-10-20 |
Cook Medical Technologies Llc |
Dilator for performing a percutaneous medical procedure
|
US20070031611A1
(en)
*
|
2005-08-04 |
2007-02-08 |
Babaev Eilaz P |
Ultrasound medical stent coating method and device
|
US9101949B2
(en)
*
|
2005-08-04 |
2015-08-11 |
Eilaz Babaev |
Ultrasonic atomization and/or seperation system
|
CA2618349C
(en)
*
|
2005-08-11 |
2016-05-31 |
Massachusetts Institute Of Technology |
Intravesical drug delivery device and method
|
US7896539B2
(en)
*
|
2005-08-16 |
2011-03-01 |
Bacoustics, Llc |
Ultrasound apparatus and methods for mixing liquids and coating stents
|
US8492428B2
(en)
*
|
2005-09-20 |
2013-07-23 |
Mayo Foundation For Medical Education And Research |
Small-molecule botulinum toxin inhibitors
|
US7540881B2
(en)
*
|
2005-12-22 |
2009-06-02 |
Boston Scientific Scimed, Inc. |
Bifurcation stent pattern
|
WO2007076160A2
(en)
*
|
2005-12-28 |
2007-07-05 |
Acidophil Llc |
C-10 carbamates of taxanes
|
US8435229B2
(en)
|
2006-02-28 |
2013-05-07 |
Olympus Endo Technology America Inc. |
Rotate-to-advance catheterization system
|
US8574220B2
(en)
|
2006-02-28 |
2013-11-05 |
Olympus Endo Technology America Inc. |
Rotate-to-advance catheterization system
|
PL2383271T3
(pl)
*
|
2006-03-13 |
2013-12-31 |
Kyorin Seiyaku Kk |
Aminochinolony jako inhibitory GSK-3
|
CA2647543A1
(en)
*
|
2006-03-29 |
2007-11-08 |
Foldrx Pharmaceuticals, Inc. |
Inhibition of alpha-synuclein toxicity
|
EP2015841A4
(de)
*
|
2006-04-27 |
2010-06-23 |
St Jude Medical |
Implantierbares medizinprodukt mit freisetzender verbindung
|
SG170032A1
(en)
|
2006-08-28 |
2011-04-29 |
Kyowa Hakko Kirin Co Ltd |
Antagonistic human light-specific human monoclonal antibodies
|
US7547323B2
(en)
*
|
2006-08-29 |
2009-06-16 |
Sinexus, Inc. |
Stent for irrigation and delivery of medication
|
PT2066662E
(pt)
|
2006-09-21 |
2013-02-13 |
Kyorin Seiyaku Kk |
Inibidores de serina-hidrolase
|
WO2008042311A1
(en)
*
|
2006-09-28 |
2008-04-10 |
Nmt Medical. Inc. |
Perforated expandable implant recovery sheath
|
US7951191B2
(en)
*
|
2006-10-10 |
2011-05-31 |
Boston Scientific Scimed, Inc. |
Bifurcated stent with entire circumferential petal
|
US20080140176A1
(en)
*
|
2006-10-18 |
2008-06-12 |
Krause Arthur A |
Medical stent and devices for localized treatment of disease
|
JP2010507585A
(ja)
|
2006-10-19 |
2010-03-11 |
オースペックス・ファーマシューティカルズ・インコーポレイテッド |
置換インドール
|
US8287519B2
(en)
*
|
2006-10-27 |
2012-10-16 |
Smith Tech Innovations, Llc |
Self-cleansing bladder drainage catheter
|
WO2008057604A2
(en)
*
|
2006-11-08 |
2008-05-15 |
The Regents Of The University Of California |
Small molecule therapeutics, syntheses of analogues and derivatives and methods of use
|
US7842082B2
(en)
*
|
2006-11-16 |
2010-11-30 |
Boston Scientific Scimed, Inc. |
Bifurcated stent
|
US20080140008A1
(en)
*
|
2006-12-06 |
2008-06-12 |
Medtronic, Inc. |
Intrathecal catheter
|
US20080142616A1
(en)
*
|
2006-12-15 |
2008-06-19 |
Bacoustics Llc |
Method of Producing a Directed Spray
|
WO2008077103A1
(en)
|
2006-12-19 |
2008-06-26 |
Auspex Pharmaceuticals, Inc. |
Preperation and utility of ccr5 inhibitors
|
JP2010513530A
(ja)
*
|
2006-12-22 |
2010-04-30 |
エンサイシブ・ファーマシューティカルズ・インコーポレイテッド |
C3a受容体の調節剤およびその使用方法
|
WO2008106167A1
(en)
*
|
2007-02-28 |
2008-09-04 |
Conatus Pharmaceuticals, Inc. |
Combination therapy comprising matrix metalloproteinase inhibitors and caspase inhibitors for the treatment of liver diseases
|
PT2144604E
(pt)
*
|
2007-02-28 |
2011-10-19 |
Conatus Pharmaceuticals Inc |
Métodos para o tratamento da hepatite c viral crónica utilizando ro-113-0830
|
PL2125698T3
(pl)
|
2007-03-15 |
2017-03-31 |
Auspex Pharmaceuticals, Inc. |
Deuterowana wenlafaksyna-d9
|
CN104069567A
(zh)
|
2007-03-19 |
2014-10-01 |
茵苏莱恩医药有限公司 |
药物输送设备
|
US8622991B2
(en)
|
2007-03-19 |
2014-01-07 |
Insuline Medical Ltd. |
Method and device for drug delivery
|
US9220837B2
(en)
|
2007-03-19 |
2015-12-29 |
Insuline Medical Ltd. |
Method and device for drug delivery
|
US8398576B2
(en)
*
|
2007-04-02 |
2013-03-19 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Removal of contrast agents from blood
|
US7892776B2
(en)
|
2007-05-04 |
2011-02-22 |
The Regents Of The University Of California |
Screening assay to identify modulators of protein kinase A
|
US20080281291A1
(en)
*
|
2007-05-07 |
2008-11-13 |
Claude Tihon |
Drainage/irrigation urethral catheter
|
US8870755B2
(en)
|
2007-05-18 |
2014-10-28 |
Olympus Endo Technology America Inc. |
Rotate-to-advance catheterization system
|
US20120149985A1
(en)
*
|
2007-05-18 |
2012-06-14 |
Frassica James J |
Rotate-to-advance catheterization system
|
US8721711B2
(en)
*
|
2007-06-20 |
2014-05-13 |
Oregon Health & Science University |
Graft having microporous membrane for uniform fluid infusion
|
CA2704920C
(en)
|
2007-06-25 |
2016-08-16 |
Microvention, Inc. |
Self-expanding prosthesis
|
US9402973B2
(en)
|
2007-07-06 |
2016-08-02 |
Vital 5, Llc |
Constrained fluid delivery device
|
EP2170062A4
(de)
*
|
2007-07-12 |
2010-12-29 |
Tragara Pharmaceuticals Inc |
Verfahren und zusammensetzungen zur behandlung von krebserkrankungen, tumoren und tumorvermittelten erkrankungen
|
US7753285B2
(en)
|
2007-07-13 |
2010-07-13 |
Bacoustics, Llc |
Echoing ultrasound atomization and/or mixing system
|
US7780095B2
(en)
|
2007-07-13 |
2010-08-24 |
Bacoustics, Llc |
Ultrasound pumping apparatus
|
EP2203458B1
(de)
*
|
2007-09-11 |
2011-11-02 |
Kyorin Pharmaceutical Co., Ltd. |
Cyanoaminochinolone als gsk-3-inhibitoren
|
US8476261B2
(en)
|
2007-09-12 |
2013-07-02 |
Kyorin Pharmaceutical Co., Ltd. |
Spirocyclic aminoquinolones as GSK-3 inhibitors
|
US7959669B2
(en)
*
|
2007-09-12 |
2011-06-14 |
Boston Scientific Scimed, Inc. |
Bifurcated stent with open ended side branch support
|
US8100855B2
(en)
*
|
2007-09-17 |
2012-01-24 |
Abbott Cardiovascular Systems, Inc. |
Methods and devices for eluting agents to a vessel
|
US20090076591A1
(en)
*
|
2007-09-19 |
2009-03-19 |
Boston Scientific Scimed, Inc. |
Stent Design Allowing Extended Release of Drug and/or Enhanced Adhesion of Polymer to OD Surface
|
US20090264421A1
(en)
*
|
2007-10-05 |
2009-10-22 |
Bible Keith C |
Methods and Compositions for Treating Cancer
|
JP5476515B2
(ja)
*
|
2007-10-09 |
2014-04-23 |
ユニヴェルシテ・パリ・デカルト |
細胞を投与するデバイス
|
SG186008A1
(en)
|
2007-11-21 |
2012-12-28 |
Pharmaxis Ltd |
Haloallylamine inhibitors of ssao/vap-1 and uses therefor
|
US7833266B2
(en)
|
2007-11-28 |
2010-11-16 |
Boston Scientific Scimed, Inc. |
Bifurcated stent with drug wells for specific ostial, carina, and side branch treatment
|
BRPI0820800B8
(pt)
*
|
2007-12-11 |
2021-06-22 |
Massachusetts Inst Technology |
dispositivo médico implantável para liberação controlada de droga
|
WO2009079388A2
(en)
*
|
2007-12-14 |
2009-06-25 |
Oregon Health & Science University |
Drug delivery cuff
|
US8409133B2
(en)
|
2007-12-18 |
2013-04-02 |
Insuline Medical Ltd. |
Drug delivery device with sensor for closed-loop operation
|
US8277501B2
(en)
*
|
2007-12-21 |
2012-10-02 |
Boston Scientific Scimed, Inc. |
Bi-stable bifurcated stent petal geometry
|
WO2009105699A1
(en)
|
2008-02-22 |
2009-08-27 |
Endologix, Inc. |
Design and method of placement of a graft or graft system
|
US8196279B2
(en)
|
2008-02-27 |
2012-06-12 |
C. R. Bard, Inc. |
Stent-graft covering process
|
PT2268623E
(pt)
|
2008-03-17 |
2015-09-17 |
Ambit Biosciences Corp |
Derivados de quinazolina como moduladores de cinase raf e métodos para utilização dos mesmos
|
US20090240318A1
(en)
*
|
2008-03-19 |
2009-09-24 |
Boston Scientific Scimed, Inc. |
Stent expansion column, strut and connector slit design
|
US20090275918A1
(en)
*
|
2008-05-01 |
2009-11-05 |
Stemcor Systems, Inc. |
Pancreatic delivery catheter
|
US8932340B2
(en)
*
|
2008-05-29 |
2015-01-13 |
Boston Scientific Scimed, Inc. |
Bifurcated stent and delivery system
|
US8617863B2
(en)
|
2008-06-04 |
2013-12-31 |
Grifols Therapeutics Inc. |
Composition, method, and kit for preparing plasmin
|
CN102176931B
(zh)
|
2008-08-09 |
2015-03-04 |
麻省理工学院 |
治疗男性泌尿生殖组织和外周组织的可植入药物递送设备和方法
|
US20110070154A1
(en)
*
|
2008-08-13 |
2011-03-24 |
Hyde Roderick A |
Artificial cells
|
CN101658533A
(zh)
*
|
2008-08-29 |
2010-03-03 |
首都医科大学宣武医院 |
抗肿瘤药物的干细胞递送
|
WO2010030728A2
(en)
*
|
2008-09-12 |
2010-03-18 |
Boston Scientific Scimed, Inc. |
Devices and systems for delivery of therapeutic agents to body lumens
|
WO2010036541A1
(en)
*
|
2008-09-24 |
2010-04-01 |
Cook Incorporated |
Catheter system having variable stiffness
|
WO2010041084A1
(en)
*
|
2008-10-09 |
2010-04-15 |
Plethora Solutions Ltd |
Medical device
|
WO2010059364A2
(en)
*
|
2008-10-30 |
2010-05-27 |
Epitek, Inc. |
Method and apparatus for sub-xiphoid delivery of therapeutic agents
|
EP2355758A2
(de)
|
2008-11-07 |
2011-08-17 |
Insuline Medical Ltd. |
Arzneimittelabgabevorrichtung und -verfahren
|
WO2010088450A2
(en)
|
2009-01-30 |
2010-08-05 |
Celladon Corporation |
Methods for treating diseases associated with the modulation of serca
|
US8568793B2
(en)
|
2009-02-11 |
2013-10-29 |
Hope Medical Enterprises, Inc. |
Sodium nitrite-containing pharmaceutical compositions
|
PT2401267E
(pt)
|
2009-02-27 |
2014-04-10 |
Ambit Biosciences Corp |
Derivados de quinazolina moduladores de quinase jak e sua utilização em métodos
|
US9206410B2
(en)
|
2009-03-03 |
2015-12-08 |
Grifols Therapeutics Inc. |
Compositions, methods and kits for preparing plasminogen and plasmin prepared therefrom
|
US8193372B2
(en)
|
2009-03-04 |
2012-06-05 |
Idenix Pharmaceuticals, Inc. |
Phosphothiophene and phosphothiazole HCV polymerase inhibitors
|
MX2011009413A
(es)
|
2009-03-11 |
2011-10-21 |
Ambit Biosciences Corp |
Combinacion de una indazolilaminopirrolotriazina y taxano para tratamiento contra cancer.
|
CN102421784B
(zh)
*
|
2009-03-11 |
2015-09-30 |
杏林制药株式会社 |
作为gsk-3抑制剂的7-环烷基氨基喹诺酮
|
WO2010110686A1
(en)
|
2009-03-27 |
2010-09-30 |
Pathway Therapeutics Limited |
Pyrimidinyl and 1,3,5 triazinyl benzimidazoles and their use in cancer therapy
|
RU2011143359A
(ru)
|
2009-03-27 |
2013-05-10 |
Патвэй Терапьютикс, Инк. |
Примидинил- и 1,3,5-триазинилбензимидазолсульфонамиды и их применение в терапии рака
|
CA2758985A1
(en)
|
2009-04-22 |
2010-10-28 |
Axikin Pharmaceuticals, Inc. |
2,5-disubstituted arylsulfonamide ccr3 antagonists
|
NZ620074A
(en)
|
2009-04-22 |
2015-09-25 |
Axikin Pharmaceuticals Inc |
2,5-disubstituted arylsulfonamide ccr3 antagonists
|
MX2011011141A
(es)
|
2009-04-22 |
2012-02-13 |
Axikin Pharmaceuticals Inc |
Antagonistas ccr3 arisulfonamida.
|
EP2429452B1
(de)
|
2009-04-28 |
2020-01-15 |
Endologix, Inc. |
Endoluminales prothesensystem
|
US20100292641A1
(en)
*
|
2009-05-15 |
2010-11-18 |
Bandula Wijay |
Targeted drug delivery device and method
|
ES2401007T3
(es)
|
2009-06-26 |
2013-04-16 |
Taris Biomedical, Inc. |
Dispositivos de administración de fármaco implantables y procedimientos de fabricación de los mismos
|
WO2011003870A2
(en)
|
2009-07-06 |
2011-01-13 |
Creabilis S.A. |
Mini-pegylated corticosteroids, compositions including same, and methods of making and using same
|
TW201105662A
(en)
|
2009-07-07 |
2011-02-16 |
Pathway Therapeutics Ltd |
Pyrimidinyl and 1,3,5-triazinyl benzimidazoles and their use in cancer therapy
|
PT2451435T
(pt)
|
2009-07-08 |
2018-01-15 |
Hope Medical Entpr Inc D B A Hope Pharmaceuticals |
Composições farmacêuticas que contêm tiossulfato de sódio
|
US20110022026A1
(en)
|
2009-07-21 |
2011-01-27 |
Lake Region Manufacturing, Inc. d/b/a Lake Region Medical. Inc. |
Methods and Devices for Delivering Drugs Using Drug-Delivery or Drug-Coated Guidewires
|
US8404728B2
(en)
|
2009-07-30 |
2013-03-26 |
Mayo Foundation For Medical Education And Research |
Small-molecule botulinum toxin inhibitors
|
JP2013501068A
(ja)
|
2009-08-05 |
2013-01-10 |
アイディニックス ファーマシューティカルズ インコーポレイテッド |
大環状セリンプロテアーゼ阻害剤
|
KR20120059558A
(ko)
|
2009-08-19 |
2012-06-08 |
암비트 바이오사이언시즈 코포레이션 |
바이아릴 화합물 및 이의 사용 방법
|
US9017312B2
(en)
|
2009-09-10 |
2015-04-28 |
Taris Biomedical Llc |
Implantable device for controlled drug delivery
|
TW201120037A
(en)
|
2009-10-26 |
2011-06-16 |
Sunesis Pharmaceuticals Inc |
Compounds and methods for treatment of cancer
|
WO2011056764A1
(en)
|
2009-11-05 |
2011-05-12 |
Ambit Biosciences Corp. |
Isotopically enriched or fluorinated imidazo[2,1-b][1,3]benzothiazoles
|
WO2011057214A2
(en)
|
2009-11-09 |
2011-05-12 |
Neurogenetic Pharmaceuticals, Inc. |
Gamma-secretase modulatory compounds, methods for identifying same, and uses therefor
|
WO2011069002A1
(en)
|
2009-12-02 |
2011-06-09 |
Alquest Therapeutics, Inc. |
Organoselenium compounds and uses thereof
|
JP2013514982A
(ja)
|
2009-12-18 |
2013-05-02 |
イデニク プハルマセウティカルス,インコーポレイテッド |
5,5−縮合アリーレン又はヘテロアリーレンc型肝炎ウイルス阻害剤
|
EP2515654A4
(de)
*
|
2009-12-23 |
2013-04-24 |
Map Pharmaceuticals Inc |
Neue ergolinanaloga
|
WO2011094890A1
(en)
|
2010-02-02 |
2011-08-11 |
Argusina Inc. |
Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators
|
DK2542542T3
(en)
|
2010-03-02 |
2015-07-20 |
Axikin Pharmaceuticals Inc |
ISOTOPIC ENRICHED ARYL SULPHONAMIDE CCR3 ANTAGONISTS
|
WO2011112689A2
(en)
|
2010-03-11 |
2011-09-15 |
Ambit Biosciences Corp. |
Saltz of an indazolylpyrrolotriazine
|
AR080770A1
(es)
|
2010-03-17 |
2012-05-09 |
Axikin Pharmaceuticals Inc |
Piperidinsulfonamidas moduladoras de la actividad de receptores xcc3, composiciones farmaceuticas que las contienen y uso de las mismas en el tratamiento de patologias respiratorias,tales como asma, entre otras.
|
WO2011140177A1
(en)
*
|
2010-05-05 |
2011-11-10 |
Cook Medical Technologies Llc |
Intraluminal treatment apparatus, wire guide and treatment fluid delivery method
|
WO2011140186A1
(en)
|
2010-05-05 |
2011-11-10 |
Cook Medical Technologies Llc |
Treatment fluid delivery method, and turbulator for promoting uptake of a treatment agent
|
US9265913B2
(en)
|
2010-09-22 |
2016-02-23 |
Vital 5, Llc |
Catheter assembly
|
WO2011150201A2
(en)
|
2010-05-27 |
2011-12-01 |
Ambit Biosciences Corporation |
Azolyl amide compounds and methods of use thereof
|
WO2011150198A1
(en)
|
2010-05-27 |
2011-12-01 |
Ambit Biosciences Corporation |
Azolyl urea compounds and methods of use thereof
|
JP6019015B2
(ja)
|
2010-06-01 |
2016-11-02 |
ビオトヘルイク, インコーポレイテッド |
6−シクロヘキシル−1−ヒドロキシ−4−メチル−2(1h)−ピリドンを使用する血液悪性疾患の治療方法
|
CN103038216A
(zh)
|
2010-06-01 |
2013-04-10 |
拜欧赛里克斯公司 |
羟基吡啶酮衍生物、其药物组合物及其用于治疗增生性疾病的治疗用途
|
CN103108868B
(zh)
|
2010-06-07 |
2015-11-25 |
诺沃梅迪科斯有限公司 |
呋喃基化合物及其用途
|
WO2011163636A2
(en)
|
2010-06-24 |
2011-12-29 |
The Regents Of The University Of California |
Compounds and uses thereof in modulating levels of various amyloid beta peptide alloforms
|
EP2595615A1
(de)
|
2010-07-19 |
2013-05-29 |
Summa Health System |
Vitamin c und chromfreies vitamin k sowie zusammensetzungen daraus zur behandlung von nfkb-induzierten leiden oder erkrankungen
|
WO2012030917A1
(en)
|
2010-09-01 |
2012-03-08 |
Ambit Biosciences Corporation |
An optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereof
|
US20130317045A1
(en)
|
2010-09-01 |
2013-11-28 |
Ambit Biosciences Corporation |
Thienopyridine and thienopyrimidine compounds and methods of use thereof
|
US20130303533A1
(en)
|
2010-09-01 |
2013-11-14 |
Ambit Biosciences Corporation |
Azolopyridine and azolopyrimidine compounds and methods of use thereof
|
US20130296363A1
(en)
|
2010-09-01 |
2013-11-07 |
Ambit Biosciences Corporation |
Quinoline and isoquinoline derivatives for use as jak modulators
|
EP2611793A1
(de)
|
2010-09-01 |
2013-07-10 |
Ambit Biosciences Corporation |
2-cyclochinazolinderivate und verwendungsverfahren dafür
|
EP2611789A1
(de)
|
2010-09-01 |
2013-07-10 |
Ambit Biosciences Corporation |
Chinazolinverbindungen und anwendungsverfahren dafür
|
US20130225614A1
(en)
|
2010-09-01 |
2013-08-29 |
Ambit Biosciences Corporation |
4-azolylaminoquinazoline derivatives and methods of use thereof
|
ES2619850T3
(es)
|
2010-09-01 |
2017-06-27 |
Ambit Biosciences Corporation |
Sales de hidrobromuro de una pirazolilaminoquinazolina
|
WO2012030918A1
(en)
|
2010-09-01 |
2012-03-08 |
Ambit Biosciences Corporation |
Adenosine a3 receptor modulating compounds and methods of use thereof
|
US20130225578A1
(en)
|
2010-09-01 |
2013-08-29 |
Ambit Biosciences Corporation |
7-cyclylquinazoline derivatives and methods of use thereof
|
US9446224B2
(en)
|
2010-09-22 |
2016-09-20 |
Vital 5, L.L.C. |
Barrier catheter
|
WO2012044641A1
(en)
|
2010-09-29 |
2012-04-05 |
Pathway Therapeutics Inc. |
1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy
|
IT1402059B1
(it)
*
|
2010-09-29 |
2013-08-28 |
Rand Srl |
Sistema indossabile per eseguire terapie depurative di fluidi organici con l'impiego di circuiti extracorporei
|
EP2627635A1
(de)
|
2010-10-11 |
2013-08-21 |
Axikin Pharmaceuticals, Inc. |
Salze aus arylsulfonamid-ccr3-antagonisten
|
TWI556849B
(zh)
|
2010-10-21 |
2016-11-11 |
美敦力阿福盧森堡公司 |
用於腎臟神經協調的導管裝置
|
BR112013010000A2
(pt)
|
2010-10-25 |
2017-10-24 |
Medtronic Ardian Luxembourg |
aparelho de cateter
|
EP2635241B1
(de)
|
2010-11-02 |
2019-02-20 |
Endologix, Inc. |
Vorrichtung zur positionierung einer gefässprothese bzw. eines gefässprothesensystems
|
US20140079686A1
(en)
|
2010-12-06 |
2014-03-20 |
Shikha P. Barman |
Methods For Treating Baldness And Promoting Hair Growth
|
WO2012080050A1
(en)
|
2010-12-14 |
2012-06-21 |
F. Hoffmann-La Roche Ag |
Solid forms of a phenoxybenzenesulfonyl compound
|
CA2823783C
(en)
|
2011-01-10 |
2023-03-21 |
Taris Biomedical, Inc. |
Lidocaine regimen for the use of sustained treatment of bladder pain and irritative voiding
|
EP2668210B1
(de)
|
2011-01-26 |
2020-06-17 |
Celldex Therapeutics, Inc. |
Anti-kit-antikörper und ihre verwendungen
|
US10052459B2
(en)
*
|
2011-01-28 |
2018-08-21 |
Cook Medical Technologies Llc |
Catheter assembly and method
|
CN103338753A
(zh)
|
2011-01-31 |
2013-10-02 |
细胞基因公司 |
胞苷类似物的药物组合物及其使用方法
|
CN103379902B
(zh)
|
2011-02-04 |
2015-11-25 |
塔里斯生物医药公司 |
用于低溶解度药物的控制释放的可植入装置
|
US9353100B2
(en)
|
2011-02-10 |
2016-05-31 |
Idenix Pharmaceuticals Llc |
Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating HCV infections
|
SG193982A1
(en)
|
2011-03-28 |
2013-11-29 |
Mei Pharma Inc |
(alpha- substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5 -triazinyl benzimidazoles, pharmaceutical compositions containing them, and these compounds for use in treating proliferative diseases
|
EP2691388A1
(de)
|
2011-03-28 |
2014-02-05 |
MEI Pharma, Inc. |
(kondensierte arylamino- und heterocyclylamino-)pyrimidynyl und 1,3,5-triazinyl-benzimidazole, pharmazeutische zusammensetzungen daraus und ihre verwendung zur behandlung von proliferativen erkrankungen
|
JP2014509648A
(ja)
|
2011-03-28 |
2014-04-21 |
メイ プハルマ,インコーポレーテッド |
(α−置換シクロアルキルアミノ及びヘテロシクリルアミノ)ピリミジニル及び1,3,5−トリアジニルベンズイミダゾール、その医薬組成物、並びに増殖性疾患の治療におけるそれらの使用
|
US20120252721A1
(en)
|
2011-03-31 |
2012-10-04 |
Idenix Pharmaceuticals, Inc. |
Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor
|
EP2694135B1
(de)
*
|
2011-04-05 |
2021-06-16 |
PharmaSens AG |
An der haut befestigte vorrichtung für intravenösen zugang
|
JP5759615B2
(ja)
|
2011-04-08 |
2015-08-05 |
コヴィディエン リミテッド パートナーシップ |
腎交感神経の除神経およびイオン導入薬物送達のためのイオン導入カテーテルシステムならびに方法
|
JP5938095B2
(ja)
*
|
2011-04-20 |
2016-06-22 |
キナメッド・インコーポレーテッド |
手術用ケーブルまたは縫合糸のための形状付与可能なパッサー
|
JP2014517076A
(ja)
|
2011-06-23 |
2014-07-17 |
マップ・ファーマシューティカルズ・インコーポレイテッド |
新規のフルオロエルゴリン類似体
|
CN103702707B
(zh)
*
|
2011-08-08 |
2016-03-30 |
奥林巴斯株式会社 |
处理器具
|
WO2013037482A1
(en)
|
2011-09-15 |
2013-03-21 |
Phenex Pharmaceuticals Ag |
Farnesoid x receptor agonists for cancer treatment and prevention
|
USD679804S1
(en)
|
2011-09-22 |
2013-04-09 |
Vital 5, Llc |
Catheter
|
US20130085468A1
(en)
*
|
2011-10-03 |
2013-04-04 |
Yuri Buydenok |
Catheter with body wall separator
|
RU2648997C2
(ru)
|
2011-10-14 |
2018-03-29 |
Эмбит Байосайенсиз Корпорейшн |
Гетероциклические соединения и способы их использования
|
CA2859173A1
(en)
|
2011-12-19 |
2013-06-27 |
Map Pharmaceuticals, Inc. |
Novel iso-ergoline derivatives
|
AU2012355983A1
(en)
|
2011-12-21 |
2015-01-22 |
Map Pharmaceuticals, Inc. |
Novel neuromodulatory compounds
|
WO2013130600A1
(en)
|
2012-02-29 |
2013-09-06 |
Ambit Biosciences Corporation |
Solid forms comprising optically active pyrazolylaminoquinazoline, compositions thereof, and uses therewith
|
US8916555B2
(en)
|
2012-03-16 |
2014-12-23 |
Axikin Pharmaceuticals, Inc. |
3,5-diaminopyrazole kinase inhibitors
|
US9044581B2
(en)
*
|
2012-03-19 |
2015-06-02 |
Cook Medical Technologies Llc |
Medical devices, methods, and kits for delivering medication to a bodily passage
|
US10258791B2
(en)
|
2012-04-27 |
2019-04-16 |
Medtronic Ardian Luxembourg S.A.R.L. |
Catheter assemblies for neuromodulation proximate a bifurcation of a renal artery and associated systems and methods
|
MX360634B
(es)
|
2012-05-02 |
2018-11-12 |
Boehringer Ingelheim Int |
Inhibidores de 3-haloalilamina sustituidos de ssao y uso de los mismos.
|
US8888773B2
(en)
|
2012-05-11 |
2014-11-18 |
Medtronic Ardian Luxembourg S.A.R.L. |
Multi-electrode catheter assemblies for renal neuromodulation and associated systems and methods
|
US9732038B2
(en)
|
2012-06-14 |
2017-08-15 |
Mayo Foundation For Medical Education And Research |
Pyrazole derivatives as inhibitors of STAT3
|
US9381326B2
(en)
|
2012-06-15 |
2016-07-05 |
W. L. Gore & Associates, Inc. |
Vascular occlusion and drug delivery devices, systems, and methods
|
US9012640B2
(en)
|
2012-06-22 |
2015-04-21 |
Map Pharmaceuticals, Inc. |
Cabergoline derivatives
|
NZ630363A
(en)
|
2012-07-25 |
2018-09-28 |
Celldex Therapeutics Inc |
Anti-kit antibodies and uses thereof
|
US9074186B2
(en)
|
2012-08-15 |
2015-07-07 |
Boston Medical Center Corporation |
Production of red blood cells and platelets from stem cells
|
AU2013312420A1
(en)
|
2012-09-07 |
2015-02-26 |
Axikin Pharmaceuticals, Inc. |
Isotopically enriched arylsulfonamide CCR3 antagonists
|
WO2014055647A1
(en)
|
2012-10-03 |
2014-04-10 |
Mei Pharma, Inc. |
(sulfinyl and sulfonyl benzimidazolyl) pyrimidines and triazines, pharmaceutical compositions thereof, and their use for treating proliferative diseases
|
US9044575B2
(en)
|
2012-10-22 |
2015-06-02 |
Medtronic Adrian Luxembourg S.a.r.l. |
Catheters with enhanced flexibility and associated devices, systems, and methods
|
US20150272924A1
(en)
|
2012-11-08 |
2015-10-01 |
Summa Health System |
Vitamin c, vitamin k, a polyphenol, and combinations thereof for wound healing
|
US9095321B2
(en)
|
2012-11-21 |
2015-08-04 |
Medtronic Ardian Luxembourg S.A.R.L. |
Cryotherapeutic devices having integral multi-helical balloons and methods of making the same
|
EP2925718B1
(de)
|
2012-11-30 |
2018-08-01 |
Novomedix, LLC |
Substituierte biarylsulfonamide und verwendung davon
|
EP3581227B1
(de)
|
2012-12-07 |
2024-02-28 |
AWAIR, Inc. |
System zum vermindern von lokalem unwohlsein
|
US9169214B2
(en)
|
2012-12-21 |
2015-10-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compounds and compositions that bind and stabilize transthyretin and their use for inhibiting transthyretin amyloidosis and protein-protein interactions
|
CA2895829A1
(en)
|
2012-12-21 |
2014-06-26 |
Map Pharmaceuticals, Inc. |
Novel methysergide derivatives
|
EP2943188A1
(de)
|
2013-01-11 |
2015-11-18 |
Mayo Foundation for Medical Education and Research |
Vitamine c und k zur behandlung polyzystischer erkrankungen
|
AU2014207836B2
(en)
*
|
2013-01-15 |
2018-06-14 |
A.V. Medical Technologies, Ltd. |
Infusion catheter with guidewire valving
|
WO2014126870A1
(en)
*
|
2013-02-12 |
2014-08-21 |
Gary Keeling |
Body cavity drainage device and methods for using the same
|
EP2968296B1
(de)
|
2013-03-12 |
2020-09-02 |
The Regents of the University of California |
Gammasekretasemodulatoren
|
US9179974B2
(en)
|
2013-03-15 |
2015-11-10 |
Medtronic Ardian Luxembourg S.A.R.L. |
Helical push wire electrode
|
RU2666684C2
(ru)
|
2013-03-15 |
2018-09-11 |
ТАРИС Биомедикал ЛЛК |
Устройство для доставки лекарственных средств с проницаемым для лекарственного средства компонентом и способ доставки лекарственных средств
|
EP2996754B1
(de)
|
2013-05-18 |
2023-04-26 |
Medtronic Ardian Luxembourg S.à.r.l. |
Neuromodulationskatheter mit wellen für verbesserter flexibilität und steuerung sowie zugehörige vorrichtungen und systeme
|
KR101548046B1
(ko)
*
|
2013-06-05 |
2015-09-04 |
이근호 |
감염 방지구조의 소아용 요도 삽입용 카테타
|
AU2014274660B2
(en)
|
2013-06-06 |
2019-05-16 |
Pierre Fabre Médicament |
Anti-C10orf54 antibodies and uses thereof
|
CN113413393A
(zh)
|
2013-08-19 |
2021-09-21 |
塔里斯生物医药公司 |
多单元药物递送装置和方法
|
WO2015031613A1
(en)
|
2013-08-30 |
2015-03-05 |
Ambit Biosciences Corporation |
Biaryl acetamide compounds and methods of use thereof
|
US20150073515A1
(en)
|
2013-09-09 |
2015-03-12 |
Medtronic Ardian Luxembourg S.a.r.I. |
Neuromodulation Catheter Devices and Systems Having Energy Delivering Thermocouple Assemblies and Associated Methods
|
NZ631142A
(en)
|
2013-09-18 |
2016-03-31 |
Axikin Pharmaceuticals Inc |
Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors
|
US20160229866A1
(en)
|
2013-09-20 |
2016-08-11 |
Idenix Pharmaceuticals Inc. |
Hepatitis c virus inhibitors
|
US10517892B2
(en)
|
2013-10-22 |
2019-12-31 |
Medtronic Minimed, Inc. |
Methods and systems for inhibiting foreign-body responses in diabetic patients
|
CN105979996B
(zh)
|
2014-01-08 |
2020-08-07 |
爱威医疗科技有限公司 |
用于对血管进行成像和治疗的装置和方法
|
WO2015113034A1
(en)
|
2014-01-27 |
2015-07-30 |
Medtronic Ardian Luxembourg S.A.R.L. |
Neuromodulation catheters having jacketed neuromodulation elements and related devices, systems, and methods
|
JP2017510328A
(ja)
*
|
2014-02-11 |
2017-04-13 |
オール ケイプ ガイナコロジー エルエルシー |
エンドサイトカニューレ
|
US10272117B2
(en)
|
2014-02-24 |
2019-04-30 |
Celgene Corporation |
Methods of using an activator of cereblon for neural cell expansion and the treatment of central nervous system disorders
|
GB201403775D0
(en)
|
2014-03-04 |
2014-04-16 |
Kymab Ltd |
Antibodies, uses & methods
|
US20170066779A1
(en)
|
2014-03-05 |
2017-03-09 |
Idenix Pharmaceuticals Llc |
Solid forms of a flaviviridae virus inhibitor compound and salts thereof
|
CA2943220C
(en)
|
2014-03-20 |
2024-01-16 |
Capella Therapeutics, Inc. |
Benzimidazole derivatives as erbb tyrosine kinase inhibitors for the treatment of cancer
|
CN106661027B
(zh)
|
2014-03-20 |
2019-12-24 |
卡佩拉医疗公司 |
苯并咪唑衍生物作为erbb酪氨酸激酶抑制剂用于治疗癌症
|
JP2017513600A
(ja)
|
2014-04-24 |
2017-06-01 |
メドトロニック アーディアン ルクセンブルク ソシエテ ア レスポンサビリテ リミテ |
編組シャフトを有する神経調節カテーテル及び関連システム及び方法
|
EP3444011A1
(de)
|
2014-05-12 |
2019-02-20 |
Conatus Pharmaceuticals, Inc. |
Behandlung der komplikationen von chronischer lebererkrankung mit emricasan
|
EP3145568B1
(de)
|
2014-05-18 |
2019-07-03 |
Cook Medical Technologies LLC |
Vorrichtung zur reduzierung von beschwerden im oberen atemweg
|
NZ726513A
(en)
|
2014-05-28 |
2023-07-28 |
Memorial Sloan Kettering Cancer Center |
Anti-gitr antibodies and methods of use thereof
|
US9527815B2
(en)
|
2014-06-18 |
2016-12-27 |
Biotheryx, Inc. |
Hydroxypyridone derivatives, pharmaceutical compositions thereof, and their therapeutic use for treating inflammatory, neurodegenerative, or immune-mediated diseases
|
US9499514B2
(en)
|
2014-07-11 |
2016-11-22 |
Celgene Corporation |
Antiproliferative compounds and methods of use thereof
|
JP6543342B2
(ja)
|
2014-08-14 |
2019-07-10 |
アルハマドシャー,マモウン,エム. |
血清半減期を延長するための、調節可能リンカーを介した薬学的活性剤とトランスサイレチンリガンドのコンジュゲーション
|
CN106999593A
(zh)
|
2014-09-12 |
2017-08-01 |
妥必徕疗治公司 |
用于纤维化治疗的赛尼克韦罗组合疗法
|
EP3209658A1
(de)
|
2014-10-24 |
2017-08-30 |
Biogen MA Inc. |
Diterpenoidderivate und verfahren zur verwendung
|
CA2966423C
(en)
|
2014-10-31 |
2023-10-24 |
The General Hospital Corporation |
Potent gamma-secretase modulators
|
WO2016094837A2
(en)
|
2014-12-11 |
2016-06-16 |
Igenica Biotherapeutics, Inc. |
Anti-c10orf54 antibodies and uses thereof
|
JP7211703B2
(ja)
|
2014-12-22 |
2023-01-24 |
ザ ロックフェラー ユニバーシティー |
抗mertkアゴニスト抗体及びその使用
|
EA032473B1
(ru)
|
2014-12-23 |
2019-05-31 |
Аксикин Фармасьютикалз, Инк. |
3,5-диаминопиразоловые ингибиторы киназы
|
BR112017015510A2
(pt)
|
2015-01-20 |
2018-01-30 |
Xoc Pharmaceuticals Inc |
composto de fórmula estrutural (i), método de tratamento e/ou prevenção, método de agonização do receptor d2 em um indivíduo, método de antagonização do receptor d3 em um indivíduo, método de agonização do receptor 5-ht1d em um indivíduo, método de agonização do receptor 5-ht1a em um indivíduo, método de agonização seletiva do receptor 5-ht1d em vez do receptor 5-ht1b em um indivíduo, método de agonização seletiva do re-ceptor 5-ht2c em vez do receptor 5-ht2a ou 5-ht2b em um indivíduo, método de agonização do receptor 5-ht2c em um indivíduo, método de fornecimento de atividade antagonista funcional no receptor 5-ht2b ou receptor 5-ht7, e, método de fornecimento de atividade antagonista funcional nos receptores adrenérgicos em um indivíduo
|
CN107428745A
(zh)
|
2015-01-20 |
2017-12-01 |
Xoc制药股份有限公司 |
麦角灵化合物及其用途
|
CN107428749B
(zh)
|
2015-01-28 |
2020-07-24 |
上海复旦张江生物医药股份有限公司 |
取代的咪唑并[1,2-α]吡啶-2-基胺化合物及其药物组合物和使用方法
|
DE112016001013T5
(de)
|
2015-03-03 |
2017-12-21 |
Kymab Limited |
Antikörper, verwendungen und verfahren
|
WO2016172704A1
(en)
|
2015-04-23 |
2016-10-27 |
Taris Biomedical Llc |
Drug delivery devices with drug-permeable component and methods
|
MA44594B1
(fr)
|
2015-05-29 |
2020-09-30 |
Memorial Sloan Kettering Cancer Center |
Anticorps anti-ctla-4 et méthodes d'utilisation de ceux-ci
|
WO2016210180A2
(en)
|
2015-06-23 |
2016-12-29 |
Neurocrine Biosciences, Inc. |
Vmat2 inhibitors for treating neurological diseases or disorders
|
US11129737B2
(en)
|
2015-06-30 |
2021-09-28 |
Endologix Llc |
Locking assembly for coupling guidewire to delivery system
|
US11229771B2
(en)
|
2015-07-20 |
2022-01-25 |
Roivios Limited |
Percutaneous ureteral catheter
|
US10918827B2
(en)
|
2015-07-20 |
2021-02-16 |
Strataca Systems Limited |
Catheter device and method for inducing negative pressure in a patient's bladder
|
RU2720403C2
(ru)
|
2015-07-20 |
2020-04-29 |
Стратака Системз Лимитед, Мт |
Мочеточниковый катетер и мочепузырный катетер и способы создания отрицательного давления для увеличения почечной перфузии
|
US10493232B2
(en)
|
2015-07-20 |
2019-12-03 |
Strataca Systems Limited |
Ureteral catheters, bladder catheters, systems, kits and methods for inducing negative pressure to increase renal function
|
US10765834B2
(en)
|
2015-07-20 |
2020-09-08 |
Strataca Systems Limited |
Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion
|
US10926062B2
(en)
|
2015-07-20 |
2021-02-23 |
Strataca Systems Limited |
Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion
|
US11040180B2
(en)
|
2015-07-20 |
2021-06-22 |
Strataca Systems Limited |
Systems, kits and methods for inducing negative pressure to increase renal function
|
US11040172B2
(en)
|
2015-07-20 |
2021-06-22 |
Strataca Systems Limited |
Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion
|
US10512713B2
(en)
|
2015-07-20 |
2019-12-24 |
Strataca Systems Limited |
Method of removing excess fluid from a patient with hemodilution
|
US11541205B2
(en)
|
2015-07-20 |
2023-01-03 |
Roivios Limited |
Coated urinary catheter or ureteral stent and method
|
CN107949573B
(zh)
|
2015-09-01 |
2022-05-03 |
艾吉纳斯公司 |
抗-pd-1抗体及其使用方法
|
PT3875459T
(pt)
|
2015-10-30 |
2024-02-21 |
Neurocrine Biosciences Inc |
Ditosilato de valbenazina e polimorfos dos mesmos
|
WO2017079566A1
(en)
|
2015-11-05 |
2017-05-11 |
Conatus Pharmaceuticals, Inc. |
Caspase inhibitors for use in the treatment of liver cancer
|
US10112924B2
(en)
|
2015-12-02 |
2018-10-30 |
Astraea Therapeutics, Inc. |
Piperdinyl nociceptin receptor compounds
|
CN108925135A
(zh)
|
2015-12-23 |
2018-11-30 |
纽罗克里生物科学有限公司 |
制备(S)-(2R,3R,11bR)-3-异丁基-9,10-二甲氧基-2,3,4,6,7,11b-六氢-1H-吡啶并[2,1-a]异喹啉-2-基2-氨基-3-甲基丁酸酯二(4-甲基苯磺酸盐)的合成方法
|
CA3010286A1
(en)
|
2015-12-31 |
2017-07-06 |
Conatus Pharmaceuticals Inc. |
Methods of using caspase inhibitors in treatment of liver disease
|
ES2959267T3
(es)
|
2016-01-08 |
2024-02-22 |
Celgene Corp |
Formas sólidas de 2-(4-clorofenil)-n-((2-2,6-dioxopiperidin-3-il)-1-oxoisoindolin-5-il)metil)-2,2-difluoroacetamida y sus composiciones farmacéuticas y usos
|
PT3399978T
(pt)
|
2016-01-08 |
2020-11-19 |
Celgene Corp |
Compostos antiproliferativos e as suas composições farmacêuticas e utilizações
|
WO2017151836A1
(en)
|
2016-03-04 |
2017-09-08 |
East Carolina University |
J-series prostaglandin-ethanolamides as novel therapeutics for skin and/or oral disorders
|
WO2017156191A1
(en)
|
2016-03-08 |
2017-09-14 |
Los Gatos Pharmaceuticals, Inc. |
Composite nanoparticles and uses thereof
|
WO2017156183A1
(en)
|
2016-03-08 |
2017-09-14 |
Los Gatos Pharmaceuticals, Inc. |
Camptothecin derivatives and uses thereof
|
JP2019513707A
(ja)
|
2016-04-11 |
2019-05-30 |
クレキシオ バイオサイエンシーズ エルティーディー. |
重水素化ケタミン誘導体
|
US10047077B2
(en)
|
2016-04-13 |
2018-08-14 |
Skyline Antiinfectives, Inc. |
Deuterated O-sulfated beta-lactam hydroxamic acids and deuterated N-sulfated beta-lactams
|
CA3018617A1
(en)
*
|
2016-04-15 |
2017-10-19 |
Temple University-Of The Commonwealth System Of Higher Education |
Infusion catheter and method of use
|
US20170319818A1
(en)
*
|
2016-05-06 |
2017-11-09 |
Cook Medical Technologies Llc |
Drug delivery device
|
EP3454904B1
(de)
|
2016-05-13 |
2022-12-14 |
Institut Pasteur |
Hemmung von beta-2-nicotinischen acetylcholinrezeptoren zur behandlung von morbus alzheimer
|
TWI753910B
(zh)
|
2016-05-16 |
2022-02-01 |
美商拜歐斯瑞克斯公司 |
吡啶硫酮、其醫藥組合物及其治療增生性、炎性、神經退化性或免疫介導疾病之治療用途
|
KR20230091191A
(ko)
|
2016-05-27 |
2023-06-22 |
아게누스 인코포레이티드 |
항-tim-3 항체 및 이의 사용 방법
|
EP3468650B1
(de)
*
|
2016-06-09 |
2020-07-15 |
Boston Scientific Scimed, Inc. |
Infusionskatheter
|
EP3481864A1
(de)
|
2016-07-08 |
2019-05-15 |
Staten Biotechnology B.V. |
Anti-apoc3-antikörper und verfahren zur verwendung davon
|
WO2018035281A1
(en)
|
2016-08-17 |
2018-02-22 |
North Carolina State University |
Northern-southern route to synthesis of bacteriochlorins
|
MA46285A
(fr)
|
2016-09-19 |
2019-07-31 |
Mei Pharma Inc |
Polythérapie
|
WO2018071500A1
(en)
|
2016-10-11 |
2018-04-19 |
Agenus Inc. |
Anti-lag-3 antibodies and methods of use thereof
|
WO2018083248A1
(en)
|
2016-11-03 |
2018-05-11 |
Kymab Limited |
Antibodies, combinations comprising antibodies, biomarkers, uses & methods
|
US11332521B2
(en)
|
2016-11-07 |
2022-05-17 |
Neuracle Science Co., Ltd. |
Anti-family with sequence similarity 19, member A5 antibodies and method of use thereof
|
US10106521B2
(en)
|
2016-11-09 |
2018-10-23 |
Phloronol, Inc. |
Eckol derivatives, methods of synthesis and uses thereof
|
AU2017356926B2
(en)
|
2016-11-09 |
2024-01-04 |
Novomedix, Llc |
Nitrite salts of 1, 1-dimethylbiguanide, pharmaceutical compositions, and methods of use
|
WO2018102252A1
(en)
|
2016-11-30 |
2018-06-07 |
North Carolina State University |
Methods for making bacteriochlorin macrocycles comprising an annulated isocyclic ring and related compounds
|
US10799503B2
(en)
|
2016-12-01 |
2020-10-13 |
Ignyta, Inc. |
Methods for the treatment of cancer
|
EP3548027A1
(de)
|
2016-12-02 |
2019-10-09 |
Neurocrine Biosciences, Inc. |
Verwendung von valbenazin zur behandlung von schizophrenie oder schizoaffektiver störung
|
BR112019011651A2
(pt)
|
2016-12-07 |
2020-01-07 |
Agenus Inc. |
Anticorpos anti-cttla-4 e métodos de uso dos mesmos
|
CN110300599A
(zh)
|
2016-12-07 |
2019-10-01 |
艾吉纳斯公司 |
抗体和其使用方法
|
MY195934A
(en)
|
2017-01-27 |
2023-02-27 |
Neurocrine Biosciences Inc |
Methods for the Administration of Certain VMAT2 Inhibitors
|
JP7307681B2
(ja)
|
2017-02-17 |
2023-07-12 |
カムリス インターナショナル インコーポレイテッド |
汎用性抗毒素
|
JP7157752B2
(ja)
|
2017-02-17 |
2022-10-20 |
エイドス セラピューティクス,インコーポレイティド |
Ag-10、その中間体及びその塩の調製方法
|
WO2018164996A1
(en)
|
2017-03-06 |
2018-09-13 |
Neurocrine Biosciences, Inc. |
Dosing regimen for valbenazine
|
SG11201908678XA
(en)
|
2017-03-27 |
2019-10-30 |
Celgene Corp |
Methods and compositions for reduction of immunogenicity
|
BR112019017241A2
(pt)
|
2017-04-13 |
2020-04-14 |
Agenus Inc |
anticorpos anti-cd137 e métodos de uso dos mesmos
|
EP3612560A1
(de)
|
2017-04-21 |
2020-02-26 |
Staten Biotechnology B.V. |
Anti-apoc3-antikörper und verfahren zur verwendung davon
|
WO2018200605A1
(en)
|
2017-04-26 |
2018-11-01 |
Neurocrine Biosciences, Inc. |
Use of valbenazine for treating levodopa-induced dyskinesia
|
US11021537B2
(en)
|
2017-05-01 |
2021-06-01 |
Agenus Inc. |
Anti-TIGIT antibodies and methods of use thereof
|
JOP20190219A1
(ar)
|
2017-05-09 |
2019-09-22 |
Cardix Therapeutics LLC |
تركيبات صيدلانية وطرق لعلاج أمراض القلب والأوعية الدموية
|
US10085999B1
(en)
|
2017-05-10 |
2018-10-02 |
Arixa Pharmaceuticals, Inc. |
Beta-lactamase inhibitors and uses thereof
|
BR112019025420A2
(pt)
|
2017-06-01 |
2020-06-16 |
Xoc Pharmaceuticals, Inc. |
Compostos policíclicos e usos destes
|
KR102327698B1
(ko)
|
2017-06-27 |
2021-11-17 |
주식회사 뉴라클사이언스 |
녹내장의 치료를 위한 항-서열 유사성 19를 가진 패밀리, 멤버 a5 항체의 용도
|
EP3645039A4
(de)
|
2017-06-27 |
2021-05-05 |
Neuracle Science Co., Ltd |
Verwendung von anti-fam19a5-antikörpern zur behandlung von fibrose
|
KR102574549B1
(ko)
|
2017-06-27 |
2023-09-07 |
주식회사 뉴라클사이언스 |
항-fam19a5 항체 및 이의 용도
|
WO2019003164A1
(en)
|
2017-06-27 |
2019-01-03 |
Neuracle Science Co., Ltd. |
USE OF ANTI-FAM19A5 ANTIBODIES FOR THE TREATMENT OF CANCERS
|
US10307566B2
(en)
|
2017-07-05 |
2019-06-04 |
Duke University |
Drainage or infusion catheter and method of use
|
EP3675866B1
(de)
|
2017-09-01 |
2023-08-02 |
East Carolina University |
Ex vivo verfahren zur aktivierung von immunzellen
|
IL273300B1
(en)
|
2017-09-21 |
2024-02-01 |
Neurocrine Biosciences Inc |
High dose valbenazine formulation and related preparations, methods and kits
|
JP2021502959A
(ja)
|
2017-10-10 |
2021-02-04 |
ニューロクライン バイオサイエンシーズ,インコーポレイテッド |
特定のvmat2インヒビターを投与するための方法
|
US10993941B2
(en)
|
2017-10-10 |
2021-05-04 |
Neurocrine Biosciences, Inc. |
Methods for the administration of certain VMAT2 inhibitors
|
BR112020008514A2
(pt)
|
2017-10-31 |
2020-10-20 |
Staten Biotechnology B.V. |
anticorpos anti-apoc3 e métodos de uso dos mesmos
|
EP3731919A1
(de)
*
|
2017-12-28 |
2020-11-04 |
Avent, Inc. |
Schnitttunneler
|
WO2019139871A1
(en)
|
2018-01-10 |
2019-07-18 |
Cura Therapeutics Llc |
Pharmaceutical compositions comprising dicarboxylic acids and their therapeutic applications
|
CA3087856A1
(en)
|
2018-01-10 |
2019-07-18 |
Cura Therapeutics, Llc |
Pharmaceutical compositions comprising phenylsulfonamides, and their therapeutic applications
|
US11116561B2
(en)
|
2018-01-24 |
2021-09-14 |
Medtronic Ardian Luxembourg S.A.R.L. |
Devices, agents, and associated methods for selective modulation of renal nerves
|
CA3094711A1
(en)
|
2018-03-23 |
2019-09-26 |
Eidos Therapeutics, Inc. |
Methods of treating ttr amyloidosis using ag10
|
US11634484B2
(en)
|
2018-04-24 |
2023-04-25 |
Neuracle Science Co., Ltd. |
Use of anti-family with sequence similarity 19, member A5 antibodies for the treatment of neuropathic pain
|
BR112020024018A2
(pt)
|
2018-06-14 |
2021-02-23 |
Neurocrine Biosciences Inc. |
compostos inibidores de vmat2, composições e métodos relacionados a eles
|
EP3814327A1
(de)
|
2018-06-29 |
2021-05-05 |
Histogen, Inc. |
(s)-3-(2-(4-(benzyl)-3-oxopiperazin-1-yl)acetamido)-4-oxo-5-(2,3,5,6-tetrafluorphenoxy)pentansäure-derivate und verwandte verbindungen als caspase-inhibitoren zur behandlung kardiovaskulärer erkrankungen
|
BR112021000934A2
(pt)
|
2018-07-20 |
2021-04-27 |
Pierre Fabre Medicament |
receptor para vista
|
JP2021528481A
(ja)
|
2018-08-15 |
2021-10-21 |
ニューロクライン バイオサイエンシーズ,インコーポレイテッド |
特定のvmat2阻害剤を投与するための方法
|
MA53238A
(fr)
|
2018-08-17 |
2022-04-13 |
Eidos Therapeutics Inc |
Formules d'ag10
|
AU2019352017A1
(en)
|
2018-10-03 |
2021-05-06 |
Staten Biotechnology B.V. |
Antibodies specific for human and cynomolgus ApoC3 and methods of use thereof
|
JP2022507606A
(ja)
|
2018-11-16 |
2022-01-18 |
ネオイミューンテック, インコーポレイテッド |
Il-7タンパク質と免疫チェックポイント阻害剤の組み合わせで腫瘍を治療する方法
|
KR20200071198A
(ko)
|
2018-12-10 |
2020-06-19 |
네오이뮨텍, 인코퍼레이티드 |
Nrf2 발현 조절 기반 T 세포 항암면역치료법
|
WO2020132071A1
(en)
|
2018-12-19 |
2020-06-25 |
Shy Therapeutics. Llc |
Compounds that interact with the ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and f1brotic disease
|
EP3921038A1
(de)
|
2019-02-06 |
2021-12-15 |
Dice Alpha, Inc. |
Il-17a modulators and uses thereof
|
WO2020176497A1
(en)
|
2019-02-26 |
2020-09-03 |
Rgenix, Inc. |
High-affinity anti-mertk antibodies and uses thereof
|
WO2020181165A1
(en)
|
2019-03-07 |
2020-09-10 |
Conatus Pharmaceuticals Inc. |
Caspase inhibitors and methods of use thereof
|
CA3138403A1
(en)
|
2019-05-20 |
2020-11-26 |
Christopher J. MACNEVIN |
Narrow emission dyes, compositions comprising same, and methods for making and using same
|
US20220274922A1
(en)
|
2019-07-11 |
2022-09-01 |
Cura Therapeutics, Llc |
Sulfone compounds and pharmaceutical compositions thereof, and their therapeutic applications
|
AU2020310190A1
(en)
|
2019-07-11 |
2022-02-24 |
Cura Therapeutics, Llc |
Phenyl compounds and pharmaceutical compositions thereof, and their therapeutic applications
|
US10940141B1
(en)
|
2019-08-23 |
2021-03-09 |
Neurocrine Biosciences, Inc. |
Methods for the administration of certain VMAT2 inhibitors
|
BR112022003740A2
(pt)
|
2019-08-30 |
2022-05-31 |
Agenus Inc |
Anticorpos anti-cd96 e métodos de uso dos mesmos
|
BR112022004802A2
(pt)
|
2019-09-16 |
2022-08-23 |
Dice Alpha Inc |
Moduladores de il-17a e usos dos mesmos
|
US20230057939A1
(en)
|
2020-01-13 |
2023-02-23 |
Neoimmunetech, Inc. |
Method of treating a tumor with a combination of il-7 protein and a bispecific antibody
|
WO2021151001A1
(en)
|
2020-01-22 |
2021-07-29 |
Outpace Bio, Inc. |
Chimeric polypeptides
|
US20230210952A1
(en)
|
2020-02-05 |
2023-07-06 |
Washington University |
Method of treating a solid tumor with a combination of an il-7 protein and car-bearing immune cells
|
CA3179635A1
(en)
|
2020-05-29 |
2021-12-02 |
Boulder Bioscience Llc |
Methods for improved endovascular thrombectomy using 3,3'-diindolylmethane
|
US20230227466A1
(en)
|
2020-06-18 |
2023-07-20 |
Shy Therapeutics, Llc |
Substituted thienopyrimidines that interact with the ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
|
US20240025863A1
(en)
|
2020-09-16 |
2024-01-25 |
Biotheryx, Inc. |
Sos1 protein degraders, pharmaceutical compositions thereof, and their therapeutic applications
|
WO2022087335A1
(en)
|
2020-10-23 |
2022-04-28 |
Biotheryx, Inc. |
Kras protein degraders, pharmaceutical compositions thereof, and their therapeutic applications
|
KR20230104176A
(ko)
|
2020-11-02 |
2023-07-07 |
네오이뮨텍, 인코퍼레이티드 |
코로나바이러스의 치료를 위한 인터류킨-7의 용도
|
EP4240408A1
(de)
|
2020-11-05 |
2023-09-13 |
Neoimmunetech, Inc. |
Verfahren zur behandlung eines tumors mit einer kombination aus einem il-7-protein und einem nukleotidimpfstoff
|
TW202237580A
(zh)
|
2020-12-14 |
2022-10-01 |
美商拜歐斯瑞克斯公司 |
Pde4降解劑、醫藥組合物及治療應用
|
WO2022165000A1
(en)
|
2021-01-27 |
2022-08-04 |
Shy Therapeutics, Llc |
Methods for the treatment of fibrotic disease
|
US20240124483A1
(en)
|
2021-01-27 |
2024-04-18 |
Shy Therapeutics, Llc |
Methods for the Treatment of Fibrotic Disease
|
EP4304716A1
(de)
|
2021-03-10 |
2024-01-17 |
Dice Molecules Sv, Inc. |
Alpha-v-beta-6- und alpha-v-beta-1-integrinhemmer und verwendungen davon
|
EP4326721A1
(de)
|
2021-04-22 |
2024-02-28 |
Protego Biopharma, Inc. |
Spirocyclische imidazolidinone und imidazolidindione zur behandlung von leichtkettiger amyloidose
|
EP4347568A1
(de)
|
2021-05-27 |
2024-04-10 |
Protego Biopharma, Inc. |
Heteroaryldiamid-ire1/xbp1s-aktivatoren
|
WO2022251644A1
(en)
|
2021-05-28 |
2022-12-01 |
Lyell Immunopharma, Inc. |
Nr4a3-deficient immune cells and uses thereof
|
US20230052243A1
(en)
|
2021-06-02 |
2023-02-16 |
Lyell Immunopharma, Inc. |
Nr4a-deficient cells expressing c-jun and uses thereof
|
WO2022263357A1
(en)
|
2021-06-14 |
2022-12-22 |
Argenx Iip Bv |
Anti-il-9 antibodies and methods of use thereof
|
WO2022266249A1
(en)
|
2021-06-16 |
2022-12-22 |
Biotheryx, Inc. |
Kras protein degraders, pharmaceutical compositions thereof, and their therapeutic applications
|
CA3222240A1
(en)
|
2021-06-16 |
2022-12-22 |
Biotheryx, Inc. |
Sos1 protein degraders, pharmaceutical compositions thereof, and their therapeutic applications
|
CN113546277B
(zh)
*
|
2021-07-23 |
2022-07-01 |
云南省阜外心血管病医院 |
一种刚度快速调整的医用导管结构
|
WO2023055045A1
(ko)
|
2021-09-29 |
2023-04-06 |
주식회사 엔바이오스 |
코일드 코일 융합 단백질
|
WO2023081923A1
(en)
|
2021-11-08 |
2023-05-11 |
Frequency Therapeutics, Inc. |
Platelet-derived growth factor receptor (pdgfr) alpha inhibitors and uses thereof
|
WO2023130081A1
(en)
|
2021-12-30 |
2023-07-06 |
Neoimmunetech, Inc. |
Method of treating a tumor with a combination of il-7 protein and vegf antagonist
|
WO2023129577A1
(en)
|
2022-01-03 |
2023-07-06 |
Lilac Therapeutics, Inc. |
Cyclic thiol prodrugs
|
WO2023192904A1
(en)
|
2022-03-30 |
2023-10-05 |
Biomarin Pharmaceutical Inc. |
Dystrophin exon skipping oligonucleotides
|
GB2619907A
(en)
|
2022-04-01 |
2023-12-27 |
Kanna Health Ltd |
Novel crystalline salt forms of mesembrine
|
WO2023201282A1
(en)
|
2022-04-14 |
2023-10-19 |
Bristol-Myers Squibb Company |
Novel gspt1 compounds and methods of use of the novel compounds
|
US20230416741A1
(en)
|
2022-05-05 |
2023-12-28 |
Biomarin Pharmaceutical Inc. |
Method of treating duchenne muscular dystrophy
|
WO2023220640A1
(en)
|
2022-05-10 |
2023-11-16 |
Biotheryx, Inc. |
Cdk protein degraders, pharmaceutical compositions, and therapeutic applications
|
WO2023225665A1
(en)
|
2022-05-19 |
2023-11-23 |
Lyell Immunopharma, Inc. |
Polynucleotides targeting nr4a3 and uses thereof
|
CN115253019B
(zh)
*
|
2022-08-11 |
2023-06-30 |
临沂市兴华医用器材有限公司 |
一种防损伤的加强型麻醉导管
|
WO2024054832A1
(en)
|
2022-09-09 |
2024-03-14 |
Innovo Therapeutics, Inc. |
CK1α AND DUAL CK1α / GSPT1 DEGRADING COMPOUNDS
|
WO2024073473A1
(en)
|
2022-09-30 |
2024-04-04 |
Boulder Bioscience Llc |
Compositions comprising 3,3'-diindolylmethane for treating non-hemorrhagic closed head injury
|